GU Ventures portfolio firm OnDosis partners with Adare Pharma Solutions to advance U.S. ADHD program
Bitget2026/10/12 07:58- GU Ventures portfolio company OnDosis entered a strategic collaboration with Adare Pharma Solutions to advance its lead U.S. ADHD program.
- Deal targets U.S. commercial manufacturing capability, supporting planned bioequivalence studies and a future regulatory filing for Imfocy.
- OnDosis develops a handheld Dosage Manager device for individualized oral-drug dosing; GU Ventures remains a shareholder.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
ECB’s Dolenc says central bank may not have to do as much if markets tighten
BlackRock CEO Larry Fink warns: AI infrastructure has become the backbone of the US economy, halting data center construction will trigger a recession
BlackRock CEO Larry Fink has issued a rare recession warning, stating that if the United States imposes any form of moratorium on data center construction, the economy will plunge directly into recession. As the midterm elections approach, the construction of AI infrastructure has escalated from a business issue to a political bombshell. Analysts predict that AI capital expenditures could surpass 1 trillion dollars by 2027. Any disruption in policy would trigger a chain reaction impacting the supply chain, job market, and energy industry.
BTC market dominance rises to 60.46%
AI Debt Glut May Be Pushing Up US Government Borrowing Costs, BondCliQ CEO Says
Crypto prices
More
